Abstract
Prolonged-action ▼guanfacine (Intuniv—Shire Pharmaceuticals Ltd) is a non-stimulant drug that has recently been licensed in Europe for the management of attention deficit hyperactivity disorder (ADHD) in children and adolescents aged...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have